Heart-Type Fatty Acid-Binding Protein in the Early Diagnosis of Acute Myocardial Infarction: The potential for influencing patient management
- PMID: 21509080
- PMCID: PMC3074640
Heart-Type Fatty Acid-Binding Protein in the Early Diagnosis of Acute Myocardial Infarction: The potential for influencing patient management
Abstract
Objectives: The objective of this study was to evaluate the diagnostic value of heart-type fatty acid-binding protein (H-FABP) in patients with acute chest pain and compare it with standard cardiac markers.
Methods: We undertook a prospective evaluation of 100 consecutive patients admitted with acute chest pain suggestive of acute coronary syndromes (ACS). Serum cardiac troponin I (cTnI), cardiac troponin T (cTnT), creatine kinase-MB (CK-MB) mass, myoglobin, and H-FABP were determined at presentation and 2, 4, 8-10, and 16-24 hours after presentation. The main outcome measure was the best sensitivity value within 6 hours after symptom onset.
Results: H-FABP peak concentration occurred at 8 hours after symptoms onset and was the most sensitive early marker with 79.9% and 98% of patients with AMI identified at presentation and 2 hours after presentation respectively. The sensitivity of all other cardiac markers (CK-MB mass, cTnI, cTnT, and myoglobin) at presentation was < 62%. The negative predictive value of H-FABP (94%) was also superior to other markers within the first 2 hours of presentation. Myoglobin was the second most sensitive early marker at presentation. Peak sensitivity of cTnI, CK-MB mass, and cTnT were present at 4, 8-10, and 8-10 hours respectively after presentation.
Conclusion: Combined measurement of H-FABP and cTnI on two occasions during the first 8 hours after symptom onset was sufficiently sensitive and specific for the early diagnosis of most patients with acute MI and may provide advantages over other cardiac marker combinations.
Keywords: Acute coronary syndromes; Acute myocardial infarction; Cardiac markers; Heart-type fatty acid-binding protein.
Figures
References
-
- British Heart Foundation Statistics Database 1999. Coronary Heart Disease Statistics. London: British Heart Foundation; 2002. 2002.
-
- Puleo PR, Meyer D, Wathen C, Tawa CW, Wheeler S, Humburg RJ, et al. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med. 1994;331:561–6. - PubMed
-
- Woo J, Lacbawan FL, Sunheimer R, McCabe JB. Is myoglobin useful in the diagnosis of acute myocardial infarction in the emergency department setting? Am J Clin Pathol. 1995;103:725–9. - PubMed
-
- Glatz JF, van Bilsen M, Paulussen RJ, Veerkamp JH, Van der Vusse GJ, Reneman RS. Release of fatty acid-binding proteins from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochem Biophys Acta. 1988;961:148–52. - PubMed
-
- Glatz JF, van der Vusse GJ, Simoons ML, Kragten JA, Van Dieijen-Visser MP, Hermens WT. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta. 1998;272:87–92. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous